通用的糖组内标制备方法和精准糖组定量研究
批准号:
32071276
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
任士芳
依托单位:
学科分类:
糖、脂生物化学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
任士芳
中文摘要
糖链标志物和功能研究及生物药质控等领域亟需实用的糖组定量方法。质谱是分析复杂糖组最有效手段之一。常以内标校正质谱分析,但简单的内标组成难以实现种类和丰度多样的糖组的准确校正,申请人曾在匀相中把N-糖的半缩醛基一步还原成氘代醇羟基,得到与实际N-糖组糖链数目、种类及丰度均相似的糖组内标,实现了N-糖组精准定量,但该方法不适于O-糖组定量。本项目拟通过氨基反应把糖蛋白固定在醛基固体上再进行唾液酸保护,然后用糖苷酶释放N-糖组并一步还原成氘代醇羟基制备N-糖组内标;再非还原性β-消除释放制备半缩醛羟基O-糖组内标。采用相似的简单流程依次获得样品中的半缩醛基N-糖组和氘代醇羟基O-糖组,针对O-糖组仅改用还原性β-消除结合NaBD4。本项目仅通过成熟的反应在同一流程中可为糖组中每个糖链提供量身定做的内标,实现N-糖组和O-糖组简便、通量、准确的定量,为挖掘胰腺癌等疾病糖链标志物提供有效方法和数据。
英文摘要
Practical glycome quantitative methods are urgently needed in the fields of disease marker discovery, protein glycosylation function research and quality control of biopharmaceuticals. Mass spectrometry is one of the most effective methods for protein glycosylation analysis. Internal standard is commonly used to reduce the errors induced by fluctuation in the ionization efficiencies of various glycans and instrument response among different runs. However, simple kinds of internal standard cannot accurately correct complex glycans in glycome. The applicant has reduced the hemiacetal group of N-glycans to deuterated alditol group in liquid homogenization phase and synthesized the internal standard of N-glycome which was similar in glycan number, composition and abundance to the N-glycome to be analyzed, finally achieving precise N-glycome quantitation. However, this method is not applicable for O-glycome quantitation. In this project, the glycoprotein was immobilized on an aldehyde solid by amide reaction followed by sialic acid protection, and then the N-glycome was released by glycosidase and reduced to deuterated alditol group in one step to prepare the N-glycome internal standard. The internal standard of O-glycome was prepared with non-reducing elimination which has the hemiacetal hydroxyl group in the reducing end. A similar simple process was used to obtain the hemiacetal N-glycome and deuterated alditol O-glycome in the sample in turn. Only the reductive β-elimination combined with NaBD4 was used for the O-glycome. This project provides a general method for preparation of internal standard for each glycan in the glycome in one pipeline only through mature reactions and hence developed a simple, high-throughput and accurate quantification of N- glycome and O-glycome, which provides an effective method to discover glycan markers of pancreatic cancer and other diseases.
本项目围绕糖组学定量分析技术开展研究,系统完成了糖组内标的制备与表征、基于内标的定量方法开发及临床样本验证等关键任务。主要创新成果包括:(1)建立了优化的O-糖组制备新方法,通过引入3 Da分子量差异标记和还原性β-消除反应,有效抑制糖链剥离(peeling)效应,完整保留O-糖链天然结构特征,实现单个流程内为各糖链提供定制化内标;(2)开发了N/O-糖组一体化定量技术平台,其中从猪胃黏蛋白中成功制备35个O-糖内标,定量分析显示所有O-糖链变异系数(CV)均<15%(其中31个CV<10%),典型糖链H2N3F1和H2N4在100倍动态范围内呈现优异线性(R²>0.999);(3)构建了基于糖组内标的高通量定量技术体系,已成功应用于唾液、血小板及细胞样本分析,其中基于N-糖内标的血清糖标志物研究在衰老和自免病领域取得突破,该部分成果已发表于学术期刊。本研究为肿瘤等重大疾病的糖链生物标志物发现提供了创新方法学支撑和关键数据支持,具有重要科学价值和应用前景。
平分型N-糖链在卵巢癌干细胞中的作用和机制研究
-
批准号:31770858
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2017
-
负责人:任士芳
-
依托单位:
CLEC-2 N-糖基化修饰的鉴定及其对生物学功能的影响
-
批准号:31100586
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:任士芳
-
依托单位:
国内基金
海外基金